CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene-dependent mitogenic responses of mast cells

Blood

Volumn 110, Issue 9, 2007, Pages 3263-3270

  Jiang, Yongfeng ^a,b   Borrelli, Laura A ^c   Kanaoka, Yoshihide ^a,b   Bacskai, Brian J ^c   Boyce, Joshua A ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Smith Research Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLLEUKOTRIENE 1 RECEPTOR; CYSTEINYLLEUKOTRIENE 2 RECEPTOR; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG; CYSTEINE; CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYSTEINYL-LEUKOTRIENE; LEUKOTRIENE; LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENERGY TRANSFER; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; KNOCKOUT GENE; MAST CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; HELA CELL; METABOLISM; MITOSIS; MOUSE MUTANT; PHYSIOLOGY; PROTEIN BINDING; TRANSACTIVATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYSTEINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HELA CELLS; HUMANS; LEUKOTRIENE D4; LEUKOTRIENES; MAST CELLS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOSIS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, LEUKOTRIENE; TRANS-ACTIVATION (GENETICS);

EID: 36148941367     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-07-100453     Document Type: Article

References (35)

1. 4 in asthmatic subjects. Am Rev Respir Dis. 1992;146:577-580.
2. Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol. 1998;102:177-183.
3. 4 synthase. J Biol Chem. 2001;276:22608-22613.
4. 1 receptor. Nature. 1999;399:789-793.
5. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000;275:30531-30536.
6. Ciana P, Fumagalli M, Trincavelli ML, et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 2006;25:4615-4627.
7. Beller TC, Maekawa A, Friend DS, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycininduced pulmonary fibrosis in mice. J Biol Chem. 2004;279:46129-46134.
8. Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signaling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy. 2003;33:1380-1388.
9. Casale TB, Wood D, Richerson HB, Zehr B, Zavala D, Hunninghake GW. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction. J Clin Invest. 1987;80:1507-1511.
10. Rottem M, Mekori YA. Mast cells and autoimmunity. Autoimmunity Rev. 2005;4:21-27.
11. Mellor EA, Maekawa A, Austen KF, Boyce JA. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A. 2001;98:7964-7969.
12. Lin DA, Boyce JA. Interleukin 4 regulates the expression of mitogen-activated protein kinase kinase-1 necessary for cytokine generation by human mast cells. J Immunol. 2005;75:5430-5438.
13. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med. 2002;195:583-592.
14. Jiang Y, Kanaoka Y, Feng C, Nocka K, Rao S, Boyce JA. Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J Immunol. 2006;177:2755-2759.
15. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978;52:447-452.
16. Kim DC, Hsu FI, Barrett NA, et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J Immunol. 2006;176:4440-4448.
17. Lleo A, Berezovska O, Herl L, et al. Nonsteroidal anti-inflammatory drugs lower Aβ 42 and change presenilin 1 conformation. Nat Med. 2004;10:1065-1066.
18. Kirshenbaum AS, Akin C, Wu Y, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia: activation following aggregation of Fcε RI or FcγRI. Leukemia Res. 2003;27:677-682.
19. Ochi H, Hirani WM, Yuan Q, Friend D, Austen KF, Boyce JA. T helper type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med. 1999;190:267-280.
20. Maekawa A, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem. 2002;277:20820-20824.
21. Mellor EA, Frank N, Soler D, et al. Expression of the type 2 cysteinyl leukotriene receptor by human mast cells; demonstration of function distinct from that of CysLTR1. Proc Natl Acad Sci U S A. 2003;100:11589-11593.
22. Berezovska O, Ramdya P, Skoch J, Wolfe MS, Bacskai BJ, Hyman BT. Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-γ -secretase complex in cells demonstrated by fluorescence lifetime imaging. J Neurosci. 2003;23:4560-4566.
23. Yoshisue H, Kirkham-Brown J, Healey E, Holgate ST, Sampson AP, Davies DE. Cysteinyl-leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts. J Allergy Clin Immunol. 2007;119:132-140.
24. Furumoto Y, Brooks S, Olivera A, et al. Cutting edge: lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J Immunol. 2006;176:5167-5171.
25. 2 in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol. 2005;115:316-322.
26. Calver AR, Robbins MJ, Cosio C, et al. The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci. 2001;21:1203-1210.
27. 3-adrenergic receptors generates a β-adrenergic signaling unit with distinct functional properties. J Biol Chem. 2004;279:28756-28765.
28. 1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res. 2005;65:732-742.
29. Randal AK, Skoch J, Bacskai BJ, et al. The membrane organization of leukotriene synthesis. Proc Natl Acad Sci U S A. 2004;101:6587-6592.
30. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstein S, Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A. 2006;103:16394-16399.
31. 1 antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochem Pharmacol. 2005;71:115-125.
32. 2-adrenergic receptors within a unique heterodimeric complex. J Clin Invest. 2006;116:1400-1409.
33. Bacskai BJ, Skoch J, Hickey GA, Allen R, Hyman BT. Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloidbeta plaques. J Biomed Opt. 2003;8:368-375.
34. 4 is associated with asthma. Pharmacogenetics. 2004;14:627-633.
35. Beller TC, Friend DS, Maekawa A, Lam BK, Austen KF, Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci U S A. 2004;101:3047-3052.